In preclinical study, Sylvester researchers target treatment-resistant prostate cancer with oral chemotherapy that works 2 ways
The chemotherapy drug cisplatin is bound to a tumor-directed nanoparticle in an approach that...
Read MoreThe chemotherapy drug cisplatin is bound to a tumor-directed nanoparticle in an approach that...
Read MoreDr. Amy Mostafavi offers world-class care and a variety of surgical procedures for patients on...
Read MoreDr. Robert Scoma earns the record-breaking achievement with Tampa General Hospital, providing...
Read MoreJUNE 30, 2023 – The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has selected...
Read MoreCollaboration on lab services will accelerate clinical trials to better impact patient care JULY 11, 2023 – CLEVELAND, OH and JOHNSON CITY, TN: Cleveland Clinic Laboratories and LabConnect have announced a strategic...
Read More